Cerrato Clara, Patel Devin, Autorino Riccardo, Simone Giuseppe, Yang Bo, Uzzo Robert, Porpiglia Francesco, Capitanio Umberto, Porter James, Beksac Alp Tuna, Minervini Andrea, Antonelli Alessandro, Cerruto Maria Angela, Lau Clayton, Ashrafi Akbar, Eun Daniel, Mottrie Alexandre, Mir Carmen, Meagher Margaret F, Puri Dhruv, Nguyen Mimi, Dhanji Sohail, Liu Franklin, Pandolfo Savio D, Kutikov Alexander, Montorsi Francesco, Gill Inderbir S, Sundaram Chandru, Kaouk Jihad, Derweesh Ithaar H
Department of Urology, UC San Diego School of Medicine, 3855 Health Sciences Drive, Mail Code 0987, La Jolla, CA, 92093-0987, USA.
Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
World J Urol. 2023 Mar;41(3):747-755. doi: 10.1007/s00345-023-04279-1. Epub 2023 Mar 1.
To compare outcomes of robotic-assisted partial nephrectomy (RAPN) and minimally invasive radical nephrectomy (MIS-RN) for complex renal masses (CRM).
We conducted a retrospective multicenter analysis of CRM patients who underwent MIS-RN and RAPN. CRM was defined as RENAL score 10-12. Primary outcome was overall survival (OS). Secondary outcomes were cancer-specific survival (CSS), recurrence, and complications. Multivariable analysis (MVA) and Kaplan-Meier Analysis (KMA) were used to analyze functional and survival outcomes for RN vs. PN by pathological stage.
926 patients were analyzed (MIS-RN = 437/RAPN = 489; median follow-up 24.0 months). MVA demonstrated lack of transfusion (HR = 1.63, p = 0.005), low-grade (HR = 1.18, p = 0.018) and smaller tumor size (HR = 1.05, p < 0.001) were associated with OS. Younger age (HR = 1.01, p = 0.017), high-grade (HR = 1.18, p = 0.017), smaller tumor size (HR = 1.05, p < 0.001), and lack of transfusion (HR = 1.39, p = 0.038) were associated with CSS. Increasing tumor size (HR = 1.18, p < 0.001), high-grade (HR = 3.21, p < 0.001), and increasing age (HR = 1.02, p = 0.009) were independent risk factors for recurrence. Type of surgery was not associated with major complications (p = 0.094). For KMA of MIS-RN vs. RAPN for pT1, pT2 and pT3, 5-year OS was 85% vs. 88% (p = 0.078); 82% vs. 80% (p = 0.442) and 84% vs. 83% (p = 0.863), respectively. 5-year CSS was 98% for both procedures (p = 0.473); 94% vs. 92% (p = 0.735) and 91% vs. 90% (p = 0.581). 5-year non-CSS was 87% vs. 93% (p = 0.107); 87% for pT2 (p = 0.485) and 92% for pT3 for both procedures (p = 0.403).
RAPN in CRM is not associated with increased risk of complications or worsened oncological outcomes when compared to MIS-RN and may be preferred when clinically indicated.
比较机器人辅助部分肾切除术(RAPN)和微创根治性肾切除术(MIS-RN)治疗复杂肾肿物(CRM)的疗效。
我们对接受MIS-RN和RAPN的CRM患者进行了一项回顾性多中心分析。CRM定义为RENAL评分10 - 12分。主要结局为总生存期(OS)。次要结局为癌症特异性生存期(CSS)、复发和并发症。采用多变量分析(MVA)和Kaplan-Meier分析(KMA)按病理分期分析根治性肾切除术(RN)与部分肾切除术(PN)的功能和生存结局。
共分析926例患者(MIS-RN = 437例/RAPN = 489例;中位随访时间24.0个月)。MVA显示未输血(HR = 1.63,p = 0.005)、低级别(HR = 1.18,p = 0.018)和肿瘤较小(HR = 1.05,p < 0.001)与OS相关。年龄较小(HR = 1.01,p = 0.017)、高级别(HR = 1.18,p = 0.017)、肿瘤较小(HR = 1.05,p < 0.001)和未输血(HR = 1.39,p = 0.038)与CSS相关。肿瘤大小增加(HR = 1.18,p < 0.001)、高级别(HR = 3.21,p < 0.001)和年龄增加(HR = 1.02,p = 0.009)是复发的独立危险因素。手术方式与主要并发症无关(p = 0.094)。对于pT1、pT2和pT3的MIS-RN与RAPN的KMA分析,5年OS分别为85%对88%(p = 0.078);82%对80%(p = 0.442)和84%对83%(p = 0.863)。两种手术的5年CSS均为98%(p = 0.473);pT2时为94%对92%(p = 0.735),pT3时两种手术均为91%对90%(p = 0.581)。5年非CSS为87%对93%(p = 0.107);pT2时为87%(p = 0.485),pT3时两种手术均为92%(p = 0.403)。
与MIS-RN相比,CRM患者行RAPN不会增加并发症风险或使肿瘤学结局恶化,临床有指征时可能更可取。